1. Home
  2. Strategy
  3. Changing Demographics

Changing Demographics

We invest in

We see inequality in healthcare

The quality of healthcare is inconsistent, with variations in treatment outcomes both between and within countries and among providers. Additionally, there are unmet patient needs due to a lack of appropriate therapeutic and diagnostic solutions. To make matters worse, healthcare costs are rising along with increasing and inefficient expenditures.

Key megatrends

Aging demographics, global population growth and new diseases.

Theme lead

tommi.unkuri@summaequity.com

Current investments

6

Exited investments

4

Investment range

EUR 40 – 200m

Invest. advisory professionals

12

Impacted SDGs

  • Good health
  • Innovation and infrastructure
  • Partnership for the goal

What are the challenges?

Variable quality of care

Treatment outcomes vary between and within countries and providers.

Large variance in cancer survival rates globally, e.g., ~8x variance for stomach cancer.

Unmet patient needs

Lack of appropriate therapeutic and diagnostic solutions.

¼ of all deaths are premature and more than 95% of rare disease patients lack an FDA-approved treatment.

Rising Healthcare Costs

Increasing and wasteful healthcare expenditure.

Costs are growing at 1–2 p.p. above GDP, e.g., 30%+ of expenditure is estimated to be waste in advanced healthcare systems.

What are the solutions?

Characterize and quantify biological molecules and their translation into function of an organism, in order to improve diagnosis and treatment.

Change molecules and biological systems for improved health.

Derive insights from datasets emanating from molecules, biological systems, and organisms.

Use data from healthcare systems to improve care.

Use technology to drive better transparency, insight, and productivity in life sciences.

Use technology to drive deployment and access of precision medicine in care delivery.

Main outcomes

  • People have access to predictable, equal and affordable care

  • Diseases are effectively diagnosed, prevented and treated

  • Improved insights, productivity, and workflows

Where do we play?

Health system – patients, providers, payors, governments

Better access, better outcomes, improved cost

Predictive, preventive, personalized, participative

Life Sciences ecosystem

  • Discover

    Understanding biological molecules and systems

    Omics tech enablement

  • Develop

    Develop and engineer biological solutions

    Omics/bio-engineering
    Tech enablement

  • Clinical development

    Test and validate solutions

    Omics/bio-engineering
    Tech enablement

  • Produce

    Production systems for deployment of care solutions

    Bioengineering
    Tech enablement

  • Prevent & diagnose

    Apply new care solutions to improve disease prevention and diagnosis

    Tech enablement
    Omics

  • Treat

    Apply new care solutions to improve disease treatment and efficiency

    Tech enablement

Investments in this theme

Latest readings

Summa Equity invests in EA Technology to accelerate the energy transition through a smarter grid

Read more

Investing in sustainable aquaculture for a resilient food system

Read more

Summa Equity acquires NetGuardians to create next generation financial crime solution

Read more

New investor Summa Equity paves way for further growth Bollegraaf Group

Read more

Summa Equity acquires Nutris to innovate sustainable plant-based nutrition

Read more

Summa Equity through NG Group acquires Fortum Recycling and Waste

Read more
1 / 6

Does your company solve global challenges?

Summa is always on the lookout for innovative organizations that are tackling global challenges and making a positive impact on the world. We are always interested in connecting with like-minded individuals and companies who share our passion for creating a sustainable future.